Product Offerings
Product Categories:
cell therapy, exosome-based therapies, cosmetic products
Products:
Entr® Cell Reprogramming Technology, Reprosome® Exosome Products, UltraRepro® Automation System, Dermal and Hair Care Products
STEMON Inc., established in 2018, specializes in cell reprogramming technologies, particularly in autologous cell therapy. Utilizing their proprietary Entr® technology, they produce customized exosomes for therapeutic and cosmetic applications. STEMON focuses on the mass production of Reprosome®, offering innovative solutions in healthcare, targeting conditions like immune and respiratory diseases. The company also develops skincare and haircare products, leveraging their expertise in cell therapy and exosome technology to grow globally.